Reduction of IGFBP2 was associated with a lower NAS score (r = 0.35, p = 0.02) and hepatocellular ballooning grade (r = 0.37, p = 0.02), but not with changes in the lobular inflammation grade (r = 0.17, p = 0.28) or steatosis grade (r = 0.17, p = 0.28) [30]. The gene discussed is IGFBP2; the disease is steatosis.